As of 2026-11-10, the EV/EBITDA ratio of Precision BioSciences Inc (DTIL) is -3.99. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DTIL's latest enterprise value is 181.15 mil USD. DTIL's TTM EBITDA according to its financial statements is -45.35 mil USD. Dividing these 2 quantities gives us the above DTIL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.6x - 17.0x | 16.0x |
| Forward P/E multiples | 16.4x - 17.9x | 17.8x |
| Fair Price | (26.82) - (28.04) | (27.79) |
| Upside | -377.0% - -389.6% | -387.1% |
| Date | EV/EBITDA |
| 2026-11-06 | -4.51 |
| 2026-11-05 | -4.10 |
| 2026-11-04 | -3.12 |
| 2026-11-03 | -2.48 |
| 2026-11-02 | -2.47 |
| 2026-10-30 | -2.53 |
| 2026-10-29 | -2.75 |
| 2026-10-28 | -2.76 |
| 2026-10-27 | -2.38 |
| 2026-10-26 | -2.17 |
| 2026-10-23 | -2.30 |
| 2026-10-22 | -2.38 |
| 2026-10-21 | -2.34 |
| 2026-10-20 | -2.25 |
| 2026-10-19 | -2.05 |
| 2026-10-16 | -1.81 |
| 2026-10-15 | -2.04 |
| 2026-10-14 | -1.96 |
| 2026-10-13 | -2.00 |
| 2026-10-12 | -2.24 |
| 2026-10-09 | -2.34 |
| 2026-10-08 | -2.18 |
| 2026-10-07 | -2.08 |
| 2026-10-06 | -2.05 |
| 2026-10-05 | -2.12 |
| 2026-10-02 | -2.12 |
| 2026-10-01 | -2.13 |
| 2026-09-30 | -2.09 |
| 2026-09-29 | -2.04 |
| 2026-09-28 | -2.08 |
| 2026-09-25 | -2.07 |
| 2026-09-24 | -2.13 |
| 2026-09-23 | -2.14 |
| 2026-09-22 | -2.61 |
| 2026-09-21 | -2.22 |
| 2026-09-18 | -2.32 |
| 2026-09-17 | -2.32 |
| 2026-09-16 | -2.29 |
| 2026-09-15 | -2.28 |
| 2026-09-14 | -2.42 |
| 2026-09-11 | -2.59 |
| 2026-09-10 | -2.63 |
| 2026-09-09 | -2.64 |
| 2026-09-08 | -2.72 |
| 2026-09-04 | -2.76 |
| 2026-09-03 | -2.71 |
| 2026-09-02 | -2.75 |
| 2026-09-01 | -2.86 |
| 2026-08-31 | -2.86 |
| 2026-08-28 | -2.94 |